MRNADIS
Live / Registered — Registered (as of 16 Aug 2022)
What this means for you
Registered since 16 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88786305
- Registration number
- 6821596
- Mark type
- Stylized text
- Filed
- 05 Feb 2020
- Published for opposition
- 28 Jul 2020
- Registered
- 16 Aug 2022
- Attorney of record
- Brendan M. Shortell
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the field of antibodies
Owner
- Elpis Biopharmaceuticals, Lexington, MA, US
- Elpis Biopharmaceuticals, Lexington, MA, US
- Elpis Biopharmaceuticals, Lexington, MA, US
Prosecution history
- 16 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Jul 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Jul 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Apr 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Mar 2022 — USE AMENDMENT FILED
- 11 Apr 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Mar 2022 — TEAS STATEMENT OF USE RECEIVED
- 22 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Sept 2021 — SOU EXTENSION 2 GRANTED
- 20 Sept 2021 — SOU EXTENSION 2 FILED
- 20 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 24 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Mar 2021 — SOU EXTENSION 1 GRANTED
- 22 Mar 2021 — SOU EXTENSION 1 FILED